Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Evaluate Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Peripheral Neuropathic Pain (AVANT)

This study has been terminated.
(The study was terminated due to results in another study (NCT00878501).)
Information provided by:
AstraZeneca Identifier:
First received: September 9, 2009
Last updated: December 21, 2009
Last verified: December 2009
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: February 2010
  Estimated Primary Completion Date: No date given